Development of glycan-targeted nanoparticles as a novel therapeutic opportunity for gastric cancer treatment

Development of glycan-targeted nanoparticles as a novel therapeutic opportunity for gastric cancer treatment

Abstract Chemotherapy resistance remains a major cause of therapeutic failure in gastric cancer. The combination of genetic material such as interference RNAs (iRNAs) to silence cancer-associated genes with chemotherapeutics has become a novel approach for cancer treatment. However, finding the righ...

Full description

Bibliographic Details
Main Authors: Sofia Nascimento dos Santos, Dino Seigo Gushiken Junior, Jhonatas Pedrosa Marim Pereira, Natália Miranda Iadocicco, André Henrique Silva, Tatielle do Nascimento, Luís Alberto Pereira Dias, Flávia Rodrigues de Oliveira Silva, Eduardo Ricci-Junior, Ralph Santos-Oliveira, Emerson Soares Bernardes
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Cancer Nanotechnology
Subjects:
Sialyl-Tn
Gastric cancer
ST6GalNAc-I
Galectin-3
Nanoparticles
Online Access:https://doi.org/10.1186/s12645-023-00161-2

Internet

https://doi.org/10.1186/s12645-023-00161-2

Similar Items